Emerging antimicrobial resistance and high prevalence of genital Mycoplasma hominis and Ureaplasma urealyticum infections among infertile women in Algeria : Implications for reproductive health
- PMID: 40699317
- DOI: 10.1007/s00508-025-02569-9
Emerging antimicrobial resistance and high prevalence of genital Mycoplasma hominis and Ureaplasma urealyticum infections among infertile women in Algeria : Implications for reproductive health
Abstract
Background: Genital infections caused by Mycoplasma hominis and Ureaplasma urealyticum are increasingly linked to female infertility, yet their epidemiology and resistance patterns remain poorly characterized in low-resource settings.
Objective: This study aimed to determine the prevalence, antimicrobial resistance (AMR) profiles, and risk factors of M. hominis and U. urealyticum infections among infertile women in Akbou, Algeria.
Methods: In this cross-sectional analysis (February-July 2024), cervicovaginal swabs from 79 infertile women were tested using the MYCOFAST® RevolutioN 2 system. Demographic, clinical, and reproductive data were collected via structured questionnaires. Statistical analyses included χ2-testsand logistic regression.
Results: The overall infection prevalence was 37.9% (n = 30), with U. urealyticum (17.7%), M. hominis (13.9%), and co-infections (6.3%) predominating. Infections peaked in women aged 31-35 years (63.3%). Resistance to tetracycline was high (U. urealyticum: 71.4%; M. hominis: 54.5%), while doxycycline and clindamycin retained full efficacy. Significant risk factors included prior abortion (adjusted odds ratio, OR = 4.2, p < 0.001), STI history (OR = 3.8, p < 0.001), and artificial insemination (OR = 2.9, p = 0.018).
Conclusion: The high prevalence of genital Mycoplasma infections and emerging AMR in Algeria underscores the need for routine screening, updated treatment guidelines, and targeted antimicrobial stewardship programs to safeguard reproductive health.
Keywords: Algeria; Female infertility; M. hominis; Reproductive risk factors; U. urealyticum.
© 2025. The Author(s), under exclusive licence to Springer-Verlag GmbH Austria, part of Springer Nature.
Conflict of interest statement
Declarations. Conflict of interest: A. Mairi, N.A. Ibrahim, T. Idres, N.S. Basher, A. Smaili, T. Idres and A. Toutati declare that they have no competing interests. Ethical standards: Institutional Review Board Statement. The experimental protocol was approved by the ethics committee of our university (N°Ethi/UMMTO/26-MAR-2024). Informed Consent Statement. Informed consent was obtained from all subjects involved in the study.
References
-
- Vander Borght M, Wyns C. Fertility and infertility: definition and epidemiology. Clin Biochem. 2018;62:2–10. - PubMed
-
- Tantengco OA, Silva M, Velayo C. The role of genital mycoplasma infection in female infertility: a systematic review and meta-analysis. Am J Reprod Immunol. 2021;85.
-
- Leli C, Mencacci A, Latino MA, Clerici P, Rassu M, Perito S, et al. Prevalence of cervical colonization by ureaplasma parvum, ureaplasma urealyticum, mycoplasma hominis and mycoplasma genitalium in childbearing age women by a commercially available multiplex real-time PCR: an Italian observational multicentre study. J Microbiol Immunol Infect. 2018;51:220–5. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Medical